This course is expiring, etc. etc. etc.
CE Credit Hours: 3.00 Continuing Education Credit Hours
CE Course Description
The safe and effective use of antipsychotic medications for children and adolescents in the United States is a critical issue in mental health and substance use treatment. The goal of this intermediate level continuing education course, developed using information from Substance Abuse and Mental Health Services Administration (SAMSHA), is to provide centralized information that articulates the scope of available systems‐level strategies to promote antipsychotic best practice prescribing for youth. The course material provides background information on antipsychotic prescribing and use among young people and intends to inform public and private sector decision‐makers, prescribing clinicians, service providers, and youth and their families of the best available evidence and corresponding recommendations.
CE Course Objectives
1. Evaluate the experiences of families and youth who are prescribed antipsychotic medications, national trends in antipsychotic medication prescribing over time, and the safety and efficacy of antipsychotic medication treatment.
2. Describe the six key principles for system-level strategies to promote antipsychotic medication oversight and best practice prescribing for youth.
3. Identify ways to engage youth and families in direct care, to improve organizational barriers and policy and to engage prescribing clinicians in making evidence-based decisions.
4. Determine how to best consider the needs of special populations at every stage of development, implementation, and evaluation of strategies for evidence‐based antipsychotic prescribing.
5. Summarize specific strategies to promote antipsychotic medication oversight and best practice prescribing.
6. Identify promising practices regarding prior authorization of antipsychotic medication for youth, the use of drug utilization reviews, elective psychiatric consultation, and shared decision-making.
7. Analyze the connection between antipsychotic medication treatment and shortages in availability of non‐pharmacological alternatives such as behavioral therapies, psychological therapies, and other psychosocial services.
8. Outline implications for research pertaining to the long‐term safety and efficacy of antipsychotic prescribing and the effectiveness of strategies to promote antipsychotic best practice prescribing.
Did you know you can now get UNLIMITED Continuing Education Credit Hours for only $95/year?
Click Here to learn more.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.